DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Big Data in Drug Discovery Digging beyond the Internet of Things-Drug Discovery Alert" report to their offering.
This edition of Drug Discovery Alert depicts the current landscape and the new trends across Big Data analytics in drug discovery. It comments on how a great number of companies and research institutions are digging beyond the Internet of Things in pharmaceutical development. The alert comprehends Big Data related topics such as cloud genomics, global influence solutions, and biomedical intelligence, among others, toward precision medicine approaches. Strategic insights explaining the impact of Big Data in the pharmaceutical industry and the overall healthcare sector, are also included along with industry and academic interactions.
The Drug Discovery Alert reports and analyzes about the latest developments in drug discovery and therapeutics, thereby providing an opportunity to acquire strategic insights into crucial developments in this industry domain. Technologies profiled include those used for biomarker and target discovery such as high throughput screening, signal transduction, micro array, RNAi, metabolomics, toxicogenomics, biosensors and nanotechnology. In addition to these, a fair focus shall be dedicated to the latest trends in therapeutic approaches across a diversity of diseases including infectious, genetic, metabolic, neurological, cardiac, and autoimmune disorders.
The Health and Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.
Key Topics Covered:
Trend Overview
- Big Data in Drug Discovery
Technology Profiles
- Cloud-enabled Genomics-centric Next-generation Company
- Leveraging Big Data for Comprehensive, Unbiased, Global Influence Solutions
- Biomedical Intelligence Cloud to Accelerate Drug Discovery and Precision MedicineData4Cure
- Biomedical Intelligence Cloud to Accelerate Drug Discovery and Precision Medicine
- Integrating Omics Big Data and Digital Biology into a Multidimensional Approach
- Big Data Management and Analysis to Address Societal Concerns
- Improving Healthcare Performance Through Big Data Applications
- Powering Cancer Care Through New Cloud-Based Software
- Using Genetic Information for Personalized Treatment Profiles
Strategic Insights
- Strategic Perspectives
Appendix
- Industry Interactions
For more information about this report visit http://www.researchandmarkets.com/research/jbg8p4/big_data_in_drug
